Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and electrophilic oxidants are a broad class of highly reactive molecules, including free radicals like superoxide (O2•−) and hydroxyl radicals (•OH), as well as non-radical oxidants like hydrogen peroxide (H2O2) and singlet oxygen (Sies et al., 2017, Nature Reviews Molecular Cell Biology). These species are primarily generated as byproducts of mitochondrial oxidative phosphorylation or through the action of enzymes such as NADPH oxidases (NOX) and xanthine oxidase (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity). In physiological conditions, they function as vital signaling molecules (redox signaling) that regulate cell growth, differentiation, and immune responses. However, an imbalance between their production and the cellular antioxidant defense systems leads to oxidative stress, which causes cumulative damage to DNA, proteins, and lipids. This damage is a central driver in the progression of various diseases, including cancer, neurodegenerative disorders (e.g., Alzheimer's and Parkinson's), and cardiovascular diseases (Schieber & Chandel, 2014, Current Biology). Pharmacological strategies to address ROS involve direct scavenging by antioxidants like Edaravone or N-acetylcysteine, or the indirect upregulation of protective enzymes via the Nrf2 pathway (e.g., Dimethyl fumarate). Despite their therapeutic potential, the non-specific nature of ROS and their requirement for normal cellular signaling make them challenging to target without disrupting essential biological processes.
Direct chemical scavenging of reactive species, neutralization of free radicals, or induction of the Nrf2-mediated antioxidant response element (ARE) pathway to increase endogenous antioxidant enzymes.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and electrophilic oxidants (ROS).